Emergent Technologies, Inc.
Venture studioAustin · Seed–Series A · 3 people tracked
Investment thesis
Emergent operates as an innovation engine that discovers and commercializes platform technologies drawn from federal labs, universities, and research institutions. Modeled on the Bell Labs tradition, its multidisciplinary team applies a four-step method — Identify, Invent, Involve, Introduce — to uncover commercial possibilities within a technology platform, expand its applications, involve partners, and launch breakthrough businesses and products. The firm provides capital and innovation access to startups and inventors seeking growth funding, small businesses seeking deployment partners, and established industry leaders looking to protect or grow their core businesses through differentiated technology.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from public directoriesWhat they invest in
from 1 of 2 portfolio companiesBiotech ×1Healthtech ×1Longevity ×1
HQs:United States×1
Investments · 2 tracked
founders shown can be your intro pathPure MHC is a drug discovery and development company using platform technology focused on HLA Class I and Class II target identification and validation, and provides contract research services in mass spectrometry, proteomics, peptidomics, epitope screening, and soluble HLA protein production.
BiotechHealthtechLongevityAustin, US
Frequently asked questions
- What stage does Emergent Technologies, Inc. invest at?
- Emergent Technologies, Inc. invests at the Seed, Series A stages.
- What sectors does Emergent Technologies, Inc. focus on?
- Emergent Technologies, Inc. focuses on Biotech, Deep Tech, Healthtech, Medical Devices.
- Where is Emergent Technologies, Inc. located?
- Emergent Technologies, Inc. is headquartered in Austin, US.
Images
Similar investors
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
Sunstone Life Science Ventures is an independent European venture capital firm focused on early-stage life science companies developing novel therapeutics for humans.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
Black Opal Ventures is a venture capital firm founded in 2021 by Tara Bishop and Eileen Tanghal, focused on investing at the intersection of healthcare and technology.
Mission BioCapital provides early-stage capital and shared lab space to life science entrepreneurs, supporting companies from idea through clinic and exit.